Cargando…
Novel albumin-binding photodynamic agent EB-Ppa for targeted fluorescent imaging guided tumour photodynamic therapy
The targeted and novel albumin-binding strategy has been attractive in the field of cancer therapy. Herein, we have developed an organic small molecule-based photosensitizer, Evans Blue-Pyropheophorbide-alpha (EB-Ppa), to treat solid tumors with extremely high photodynamic therapeutic efficiency, wh...
Autores principales: | Liu, Huan, Yu, Cheng, Lyu, Min, Lyu, Shiyi, Hu, LiNan, Xiao, Enhua, Xu, Pengfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890653/ https://www.ncbi.nlm.nih.gov/pubmed/36756591 http://dx.doi.org/10.1039/d2ra07380c |
Ejemplares similares
-
Novel albumin-binding photothermal agent ICG-IBA-RGD for targeted fluorescent imaging and photothermal therapy of cancer
por: Yu, Cheng, et al.
Publicado: (2021) -
Novel albumin-binding multifunctional probe for synergistic enhancement of FL/MR dual-modal imaging and photothermal therapy
por: Yu, Cheng, et al.
Publicado: (2023) -
Serum albumin as a vehicle for zinc phthalocyanine: photodynamic activities in solid tumour models.
por: Larroque, C., et al.
Publicado: (1996) -
Combination of Fluorescence-Guided Surgery With Photodynamic Therapy for the Treatment of Cancer
por: He, Jun, et al.
Publicado: (2017) -
Nucleus‐Targeted Organoiridium–Albumin Conjugate for Photodynamic Cancer Therapy
por: Zhang, Pingyu, et al.
Publicado: (2019)